Anvisa: Lots of the Sutent® cancer drug were counterfeit
By: Ascom / Anvisa
Posted: 03/03/2018 10:30
Last Modified: 03/03/2018 10:44
Pfizer Lab has identified 11 counterfeit lots that have not left its factory. Cancer drug is used in hospitals.
In a resolution published on Monday (5/3) in the Federal Official Gazette (DOU), Anvisa banned 11 falsified batches of the cancer drug Sutent® in the package with 28 50 mg capsules. Batches 746EE, 747EE, 748EE, 190EE, 045AA, 191EE, 189EE, 985EE, 986EE, 987EE and 749EE are falsified.
For more information go to: http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4131460